Mechanism of Action of Antipsychotics
 

Tuesday, November 19, 2002

9:00 a.m. PST / 12 Noon EST
Live question and answer session with Dr. Lieberman

11:00 a.m. PST / 2 p.m. EST
Mechanism of Action of Antipsychotics

Jeffrey Lieberman, M.D.
Vice Chairman of Psychiatry
Professor of Psychiatry and Pharmacology
University of North Carolina
School of Medicine

Description:
Dr. Jeffrey Lieberman will discuss research on the neurobiology of schizophrenia and the mechanism of action of antipsychotic drugs. He will provide an overview of new approaches for treating psychosis that do not rely on dopamine antagonism. He will also describe how discoveries in areas such as genetics, genomics, and neuroimaging have already improved our understanding of the biology of schizophrenia.

Learning Objectives:

At the conclusion of this talk the audience should be able to:

  • Understand the pharmacology and clinical effects of antipsychotic drugs.
  • Understand the comparative effectiveness of first and second generation antipsychotic drugs between the atypical APDs.